What is it about?
Ferric carboximaltose is approximately then times more expensive than ferric sucrose. It allows, however ,to infuse a much larger dose of iron (1000 vs 200 mg) in a single administration. We showed that savings in direct and indirect costs of five infusions largely overcome the increase in the cost of the drug.
Featured Image
Why is it important?
Suggest that ferric carboximaltose is not only more convenient for patients but also globally cheaper that Iron sucrose.
Perspectives
It is difficult to justify five venous punctures when the same dose may be given with only one in ambulatory patients. Furthermore, iron sucrose needs 10 days (200 mg doses should be administered every other day) while a single 30 minutes infusions of ferric carboximaltose achieves the same results.
Xavier Calvet
Universitat Autonoma de Barcelona
Read the Original
This page is a summary of: Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia, Technology and Health Care, January 2016, IOS Press,
DOI: 10.3233/thc-151074.
You can read the full text:
Contributors
The following have contributed to this page
